Listed
Stock Code: 332190
| Company Name | 오션스바이오 주식회사 |
| English Name | OceansBio Co., Ltd. |
| Business Reg. No. | 1228701163 |
| CEO | 이현웅 |
| Address | 경상남도 창원시 의창구 중동북로 235층 506호 |
| Industry | 그 외 기타 의료용 기기 제조업 |
| Industry Code | 27199 |
| Established | 20180720 |
| Phone | 070-4776-7006 |
| Website | oceansbio.com/ |
| Regular Employees | 12persons |
| Corp. Reg. No. | 1314110415896 |
Venture Certified
| 기술평가보증기업(기금) | 2019-09-03 ~ 2021-09-02 | 20190110200 | 2019-09-03 |
| 벤처투자유형 | 2021-09-03 ~ 2024-09-02 | 20210804010015 | 2019-09-03 |
| 벤처투자유형 | 2024-09-03 ~ 2027-09-02 | 20240806010025 | 2019-09-03 |
Revenue CAGR +238.9%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 1.9B | 1.3B | 0.2B |
| Operating Profit | -19B | -19B | -10B |
| Net Profit | -14B | -10B | -5.5B |
| Total Assets | 34B | 8.6B | 12B |
| Total Liabilities | 12B | 12B | 9.5B |
| Total Equity | 22B | -3.5B | 2.6B |
Operating Loss: Op. profit -19B
3 Consecutive Years of Net Loss
▲ 172.1%
▼ 34.7%
▲ 73.2%
▲ 606.2%
▼ 262.9%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 이현웅 | 사내이사 | 경영총괄 | - |
| 강귀염 | 사내이사 | CTO | - |
| 이종승 | 미등기 | 경영 관리 본부장 | - |
| 박재성 | 사내이사 | 책임 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| NPS Subscribers | 19persons |
| CEO | 이현웅 |
| Est. Avg. Annual Salary | 4,61410K (38510K/mo) |
| Hired (12 mo) | +2persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | +2persons |
| NPS Join Date | 2018-08-02 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "경상남도 창원시",
"ceo_name": "이현웅",
"certificate": [
{
"cert_number": "20190110200",
"changes": "",
"disclosure_date": "2019-09-03",
"first_cert_date": "2019-09-03",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2019-09-03 ~ 2021-09-02"
},
{
"cert_number": "20210804010015",
"changes": "",
"disclosure_date": "2021-08-04",
"first_cert_date": "2019-09-03",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2021-09-03 ~ 2024-09-02"
},
{
"cert_number": "20240806010025",
"changes": "",
"disclosure_date": "2024-08-06",
"first_cert_date": "2019-09-03",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2024-09-03 ~ 2027-09-02"
}
],
"company_name": "오션스바이오 주식회사",
"financials": {
"2022": {
"capital_stock": 174772000,
"cost_of_sales": 0,
"current_assets": 897853000,
"current_liabilities": 774171000,
"gross_profit": 16890000,
"net_income": -554104000,
"net_income_bs": -554104000,
"non_current_assets": 320230000,
"non_current_liabilities": 179836000,
"non_operating_expenses": 26974000,
"non_operating_income": 475976000,
"operating_profit": -1003106000,
"revenue": 16890000,
"sga_expenses": 1019996000,
"total_assets": 1218083000,
"total_equity": 264076000,
"total_liabilities": 954007000
},
"2023": {
"capital_stock": 180233000,
"cost_of_sales": 36540000,
"current_assets": 600887000,
"current_liabilities": 867087000,
"gross_profit": 89106000,
"net_income": -1013497000,
"net_income_bs": -1013497000,
"non_current_assets": 260088000,
"non_current_liabilities": 343787000,
"non_operating_expenses": 76811000,
"non_operating_income": 925503000,
"operating_profit": -1862189000,
"revenue": 125646000,
"sga_expenses": 1951295000,
"total_assets": 860975000,
"total_equity": -349899000,
"total_liabilities": 1210874000
},
"2024": {
"capital_stock": 218329000,
"cost_of_sales": 0,
"current_assets": 2815066000,
"current_liabilities": 912395000,
"gross_profit": 193930000,
"net_income": -1441551000,
"net_income_bs": -1441551000,
"non_current_assets": 591944000,
"non_current_liabilities": 277465000,
"non_operating_expenses": 46542000,
"non_operating_income": 534096000,
"operating_profit": -1929105000,
"revenue": 193930000,
"sga_expenses": 2123035000,
"total_assets": 3407010000,
"total_equity": 2217150000,
"total_liabilities": 1189860000
}
},
"industry": "그 외 기타 의료용 기기 제조업",
"investment": [
{
"amount": "499,999,500",
"changes": "499,999,500",
"date": "2024-06-28"
},
{
"amount": "99,000,000",
"changes": "99,000,000",
"date": "2020-06-30"
}
],
"phone": "010-9877-****",
"source": "pg_migration"
}{
"address": "경상남도 창원시 의창구 중동북로",
"brno": "122870****",
"cappedWarning": false,
"companyName": "오션스바이오주식회사",
"estimatedAvgAnnualSalary": 46144488,
"estimatedAvgMonthlySalary": 3845374,
"fetchedAt": "2026-03-05T11:40:14.987Z",
"industryCode": "730000",
"industryName": "기타 인문 및 사회과학 연구개발업",
"joinDate": "20180802",
"last12MonthsHired": 2,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 2,
"leaveDate": null,
"monthlyPensionAmount": 6940900,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 2,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6795082",
"status": "1",
"styleCode": "1",
"subscriberCount": 19,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |